These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 2160612
1. Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis. Redding SW. NCI Monogr; 1990; (9):103-5. PubMed ID: 2160612 [Abstract] [Full Text] [Related]
2. Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection. Djuric M, Jankovic L, Jovanovic T, Pavlica D, Brkic S, Knezevic A, Markovic D, Milasin J. J Oral Pathol Med; 2009 Feb; 38(2):167-73. PubMed ID: 18713235 [Abstract] [Full Text] [Related]
3. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M. Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507 [Abstract] [Full Text] [Related]
5. The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients. Woo SB, Sonis ST, Sonis AL. Cancer; 1990 Dec 01; 66(11):2375-9. PubMed ID: 2173971 [Abstract] [Full Text] [Related]
6. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis. Demarosi F, Bez C, Carrassi A. Minerva Stomatol; 2002 May 01; 51(5):173-86. PubMed ID: 12070468 [Abstract] [Full Text] [Related]
7. Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Labar B, Mrsić M, Pavletić Z, Bogdanić V, Nemet D, Aurer I, Radman I, Filipović-Grcić N, Sertić D, Kalenić S. Bone Marrow Transplant; 1993 May 01; 11(5):379-82. PubMed ID: 8504271 [Abstract] [Full Text] [Related]
8. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse. Weisdorf DJ, Bostrom B, Raether D, Mattingly M, Walker P, Pihlstrom B, Ferrieri P, Haake R, Goldman A, Woods W. Bone Marrow Transplant; 1989 Jan 01; 4(1):89-95. PubMed ID: 2647192 [Abstract] [Full Text] [Related]
12. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts. Engelhard D, Morag A, Or R, Naparstek E, Cividalli G, Ruchlemer R, Aker M, Maayan S, Slavin S. Isr J Med Sci; 1988 Mar 01; 24(3):145-50. PubMed ID: 3286577 [Abstract] [Full Text] [Related]
13. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Review. López-Castaño F, Oñate-Sánchez RE, Roldán-Chicano R, Cabrerizo-Merino MC. Med Oral Patol Oral Cir Bucal; 2005 Mar 01; 10(5):412-21. PubMed ID: 16264377 [Abstract] [Full Text] [Related]
15. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation. Iino T, Gondo H, Ohno Y, Minagawa H, Iwasaki H, Maruyama T, Nakashima H, Niho Y. Bone Marrow Transplant; 1996 Dec 01; 18(6):1185-8. PubMed ID: 8971394 [Abstract] [Full Text] [Related]
16. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study. Ramphal R, Grant RM, Dzolganovski B, Constantin J, Tellier R, Allen U, Weitzman S, Matlow A, Petric M, Sung L. Pediatr Infect Dis J; 2007 Aug 01; 26(8):700-4. PubMed ID: 17848881 [Abstract] [Full Text] [Related]
17. The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy. Epstein JB, Gorsky M, Hancock P, Peters N, Sherlock CH. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec 01; 94(6):712-6. PubMed ID: 12464896 [Abstract] [Full Text] [Related]
18. Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants. Redding SW, Montgomery MT. Oral Surg Oral Med Oral Pathol; 1989 Jun 01; 67(6):680-3. PubMed ID: 2544843 [Abstract] [Full Text] [Related]
19. Chemotherapy: the effect of oral cryotherapy on the development of mucositis. Karagözoğlu S, Filiz Ulusoy M. J Clin Nurs; 2005 Jul 01; 14(6):754-65. PubMed ID: 15946284 [Abstract] [Full Text] [Related]
20. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Lusso MR, Camboni P, Ferreli L, Mocci M, Perboni S, Mura L, Madeddu C, Macciò A. Oncol Rep; 2003 Jul 01; 10(1):197-206. PubMed ID: 12469169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]